Morgan Stanley Maravai Lifesciences Holdings, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,699,739 shares of MRVI stock, worth $15.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,699,739

Previous 1,720,348 56.93%

Holding current value

$15.1 Million

Previous $12.3 Million 82.14%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.84 - $9.73 $6.7 Million - $9.53 Million	979,391 Added 56.93%	2,699,739 $22.4 Million
Q2 2024 Oct 17, 2024	SELL	$6.87 - $11.34 $6.08 Million - $10 Million	-884,418 Reduced 33.95%	1,720,348 $12.3 Million
Q2 2024 Aug 14, 2024	SELL	$6.87 - $11.34 $6.08 Million - $10 Million	-884,418 Reduced 33.95%	1,720,348 $12.3 Million
Q1 2024 Oct 17, 2024	BUY	$5.11 - $8.76 $4.52 Million - $7.75 Million	884,418 Added 51.41%	2,604,766 $22.6 Million
Q1 2024 Aug 16, 2024	SELL	$5.11 - $8.76 $1.35 Million - $2.32 Million	-264,382 Reduced 9.21%	2,604,766 $22.6 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $1.35 Million - $2.32 Million	-264,382 Reduced 9.21%	2,604,766 $22.6 Million
Q4 2023 Aug 16, 2024	BUY	$4.7 - $9.87 $5.4 Million - $11.3 Million	1,148,800 Added 66.78%	2,869,148 $18.8 Million
Q4 2023 Feb 13, 2024	BUY	$4.7 - $9.87 $6.78 Million - $14.2 Million	1,442,909 Added 101.17%	2,869,148 $18.8 Million
Q3 2023 Nov 15, 2023	SELL	$9.14 - $12.85 $3.7 Million - $5.2 Million	-404,475 Reduced 22.09%	1,426,239 $14.3 Million
Q2 2023 Aug 14, 2023	SELL	$12.09 - $15.0 $8.49 Million - $10.5 Million	-702,218 Reduced 27.72%	1,830,714 $22.8 Million
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $9.18 Million - $11.6 Million	706,814 Added 38.71%	2,532,932 $35.5 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $6.53 Million - $13 Million	522,612 Added 40.09%	1,826,118 $26.1 Million
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $31.6 Million - $46.5 Million	-1,531,611 Reduced 54.02%	1,303,506 $33.3 Million
Q2 2022 Oct 27, 2022	SELL	$26.05 - $37.48 $205,899 - $296,241	-7,904 Reduced 0.28%	2,835,117 $80.5 Million
Q2 2022 Aug 15, 2022	SELL	$26.05 - $37.48 $205,899 - $296,241	-7,904 Reduced 0.28%	2,835,117 $80.5 Million
Q1 2022 Oct 27, 2022	BUY	$24.46 - $40.92 $193,331 - $323,431	7,904 Added 0.28%	2,843,021 $100 Million
Q1 2022 May 13, 2022	BUY	$24.46 - $40.92 $7.89 Million - $13.2 Million	322,568 Added 12.8%	2,843,021 $100 Million
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $965,930 - $1.27 Million	-27,598 Reduced 1.08%	2,520,453 $106 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $93.8 Million - $154 Million	2,548,051 New	2,548,051 $125 Million

Others Institutions Holding MRVI

# of Institutions

234

Shares Held

140M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $738M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account